Sign in to view content

Two-Year Real-World Treat and Extend Patterns and Fluid Outcomes Among Neovascular Age-Related Macular Degeneration Patients Treated With Anti-VEGFs

Michael A. Singer, MD

Video
Published 2020

Related

Modifier-25 Examinations Reduce Travel Burden, Decrease Treatment Cost, and Improve QALY for Exudative Age-Related Macular Degeneration Patients
Henry A Leder, MD
Annual Meeting Talks
2020
The Influence of Universal Face Mask Use on Endophthalmitis Risk After Intravitreal Anti-VEGF Injections During the COVID-19 Pandemic
Sunir J. Garg, MD, FACS, FASRS
Annual Meeting Talks
2021
Ten-Year Follow-Up of Patients With Exudative Age-Related Macular Degeneration Treated With Intravitreal Anti-VEGF Injections
Sophie Jane Bakri, MD
Annual Meeting Talks
2020

Category: AMD-Neovascular

See more